nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymorphone—CYP2D6—Fingolimod—multiple sclerosis	0.149	0.261	CbGbCtD
Oxymorphone—CYP3A4—Fingolimod—multiple sclerosis	0.0947	0.166	CbGbCtD
Oxymorphone—CYP3A4—Methylprednisolone—multiple sclerosis	0.061	0.107	CbGbCtD
Oxymorphone—CYP3A4—Triamcinolone—multiple sclerosis	0.0463	0.081	CbGbCtD
Oxymorphone—CYP3A4—Mitoxantrone—multiple sclerosis	0.0445	0.078	CbGbCtD
Oxymorphone—CYP3A4—Betamethasone—multiple sclerosis	0.0397	0.0695	CbGbCtD
Oxymorphone—CYP3A4—Prednisolone—multiple sclerosis	0.0392	0.0686	CbGbCtD
Oxymorphone—CYP3A4—Prednisone—multiple sclerosis	0.037	0.0648	CbGbCtD
Oxymorphone—CYP2D6—Dexamethasone—multiple sclerosis	0.0363	0.0636	CbGbCtD
Oxymorphone—CYP3A4—Dexamethasone—multiple sclerosis	0.0231	0.0404	CbGbCtD
Oxymorphone—Naloxone—TLR4—multiple sclerosis	0.00591	0.889	CrCbGaD
Oxymorphone—OPRM1—nerve—multiple sclerosis	0.00119	0.188	CbGeAlD
Oxymorphone—Naloxone—ALB—multiple sclerosis	0.000737	0.111	CrCbGaD
Oxymorphone—Dyspnoea—Mitoxantrone—multiple sclerosis	0.00055	0.00187	CcSEcCtD
Oxymorphone—Somnolence—Mitoxantrone—multiple sclerosis	0.000548	0.00187	CcSEcCtD
Oxymorphone—Loss of consciousness—Prednisolone—multiple sclerosis	0.000545	0.00185	CcSEcCtD
Oxymorphone—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000543	0.00185	CcSEcCtD
Oxymorphone—Angiopathy—Betamethasone—multiple sclerosis	0.000539	0.00184	CcSEcCtD
Oxymorphone—Angiopathy—Dexamethasone—multiple sclerosis	0.000539	0.00184	CcSEcCtD
Oxymorphone—Convulsion—Prednisolone—multiple sclerosis	0.000537	0.00183	CcSEcCtD
Oxymorphone—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000536	0.00182	CcSEcCtD
Oxymorphone—Hypertension—Prednisolone—multiple sclerosis	0.000535	0.00182	CcSEcCtD
Oxymorphone—Fatigue—Mitoxantrone—multiple sclerosis	0.000531	0.00181	CcSEcCtD
Oxymorphone—Constipation—Mitoxantrone—multiple sclerosis	0.000527	0.0018	CcSEcCtD
Oxymorphone—Pain—Mitoxantrone—multiple sclerosis	0.000527	0.0018	CcSEcCtD
Oxymorphone—Bradycardia—Prednisone—multiple sclerosis	0.000527	0.00179	CcSEcCtD
Oxymorphone—Diarrhoea—Azathioprine—multiple sclerosis	0.000522	0.00178	CcSEcCtD
Oxymorphone—Hallucination—Prednisone—multiple sclerosis	0.000515	0.00175	CcSEcCtD
Oxymorphone—OPRM1—brainstem—multiple sclerosis	0.000513	0.0806	CbGeAlD
Oxymorphone—Vertigo—Triamcinolone—multiple sclerosis	0.000512	0.00174	CcSEcCtD
Oxymorphone—Syncope—Triamcinolone—multiple sclerosis	0.000511	0.00174	CcSEcCtD
Oxymorphone—Vertigo—Methylprednisolone—multiple sclerosis	0.000511	0.00174	CcSEcCtD
Oxymorphone—Syncope—Methylprednisolone—multiple sclerosis	0.00051	0.00174	CcSEcCtD
Oxymorphone—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000508	0.00173	CcSEcCtD
Oxymorphone—Oedema—Prednisolone—multiple sclerosis	0.000506	0.00172	CcSEcCtD
Oxymorphone—Dizziness—Azathioprine—multiple sclerosis	0.000504	0.00172	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000504	0.00172	CcSEcCtD
Oxymorphone—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000501	0.00171	CcSEcCtD
Oxymorphone—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.0005	0.0017	CcSEcCtD
Oxymorphone—Shock—Prednisolone—multiple sclerosis	0.000498	0.00169	CcSEcCtD
Oxymorphone—Convulsion—Triamcinolone—multiple sclerosis	0.000494	0.00168	CcSEcCtD
Oxymorphone—Tachycardia—Prednisolone—multiple sclerosis	0.000494	0.00168	CcSEcCtD
Oxymorphone—Convulsion—Methylprednisolone—multiple sclerosis	0.000493	0.00168	CcSEcCtD
Oxymorphone—Hypertension—Triamcinolone—multiple sclerosis	0.000492	0.00168	CcSEcCtD
Oxymorphone—Hypertension—Methylprednisolone—multiple sclerosis	0.000491	0.00167	CcSEcCtD
Oxymorphone—Urticaria—Mitoxantrone—multiple sclerosis	0.00049	0.00167	CcSEcCtD
Oxymorphone—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000489	0.00166	CcSEcCtD
Oxymorphone—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000487	0.00166	CcSEcCtD
Oxymorphone—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000487	0.00166	CcSEcCtD
Oxymorphone—Vomiting—Azathioprine—multiple sclerosis	0.000485	0.00165	CcSEcCtD
Oxymorphone—Pneumonia—Methotrexate—multiple sclerosis	0.000484	0.00165	CcSEcCtD
Oxymorphone—Eye disorder—Prednisone—multiple sclerosis	0.000483	0.00165	CcSEcCtD
Oxymorphone—Anxiety—Methylprednisolone—multiple sclerosis	0.000482	0.00164	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000481	0.00164	CcSEcCtD
Oxymorphone—Dermatitis—Azathioprine—multiple sclerosis	0.00048	0.00164	CcSEcCtD
Oxymorphone—Flushing—Prednisone—multiple sclerosis	0.00048	0.00163	CcSEcCtD
Oxymorphone—Headache—Azathioprine—multiple sclerosis	0.000478	0.00163	CcSEcCtD
Oxymorphone—Dry mouth—Triamcinolone—multiple sclerosis	0.000474	0.00162	CcSEcCtD
Oxymorphone—Angiopathy—Prednisone—multiple sclerosis	0.000469	0.0016	CcSEcCtD
Oxymorphone—Confusional state—Methylprednisolone—multiple sclerosis	0.000468	0.00159	CcSEcCtD
Oxymorphone—Immune system disorder—Prednisone—multiple sclerosis	0.000467	0.00159	CcSEcCtD
Oxymorphone—Oedema—Triamcinolone—multiple sclerosis	0.000465	0.00158	CcSEcCtD
Oxymorphone—Vertigo—Betamethasone—multiple sclerosis	0.000465	0.00158	CcSEcCtD
Oxymorphone—Vertigo—Dexamethasone—multiple sclerosis	0.000465	0.00158	CcSEcCtD
Oxymorphone—Syncope—Betamethasone—multiple sclerosis	0.000464	0.00158	CcSEcCtD
Oxymorphone—Syncope—Dexamethasone—multiple sclerosis	0.000464	0.00158	CcSEcCtD
Oxymorphone—Shock—Triamcinolone—multiple sclerosis	0.000458	0.00156	CcSEcCtD
Oxymorphone—Insomnia—Prednisolone—multiple sclerosis	0.000457	0.00156	CcSEcCtD
Oxymorphone—Shock—Methylprednisolone—multiple sclerosis	0.000457	0.00155	CcSEcCtD
Oxymorphone—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000455	0.00155	CcSEcCtD
Oxymorphone—Loss of consciousness—Betamethasone—multiple sclerosis	0.000454	0.00155	CcSEcCtD
Oxymorphone—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000454	0.00155	CcSEcCtD
Oxymorphone—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000454	0.00155	CcSEcCtD
Oxymorphone—Tachycardia—Triamcinolone—multiple sclerosis	0.000454	0.00155	CcSEcCtD
Oxymorphone—Mental disorder—Prednisone—multiple sclerosis	0.000453	0.00154	CcSEcCtD
Oxymorphone—Nausea—Azathioprine—multiple sclerosis	0.000453	0.00154	CcSEcCtD
Oxymorphone—Tachycardia—Methylprednisolone—multiple sclerosis	0.000453	0.00154	CcSEcCtD
Oxymorphone—Skin disorder—Methylprednisolone—multiple sclerosis	0.000451	0.00153	CcSEcCtD
Oxymorphone—Malnutrition—Prednisone—multiple sclerosis	0.00045	0.00153	CcSEcCtD
Oxymorphone—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00045	0.00153	CcSEcCtD
Oxymorphone—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000449	0.00153	CcSEcCtD
Oxymorphone—Convulsion—Dexamethasone—multiple sclerosis	0.000448	0.00153	CcSEcCtD
Oxymorphone—Convulsion—Betamethasone—multiple sclerosis	0.000448	0.00153	CcSEcCtD
Oxymorphone—Hypertension—Dexamethasone—multiple sclerosis	0.000446	0.00152	CcSEcCtD
Oxymorphone—Hypertension—Betamethasone—multiple sclerosis	0.000446	0.00152	CcSEcCtD
Oxymorphone—Asthenia—Mitoxantrone—multiple sclerosis	0.000442	0.00151	CcSEcCtD
Oxymorphone—Anxiety—Dexamethasone—multiple sclerosis	0.000439	0.00149	CcSEcCtD
Oxymorphone—Anxiety—Betamethasone—multiple sclerosis	0.000439	0.00149	CcSEcCtD
Oxymorphone—Hypotension—Methylprednisolone—multiple sclerosis	0.000434	0.00148	CcSEcCtD
Oxymorphone—Pain—Prednisolone—multiple sclerosis	0.000432	0.00147	CcSEcCtD
Oxymorphone—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000427	0.00145	CcSEcCtD
Oxymorphone—Vision blurred—Prednisone—multiple sclerosis	0.000424	0.00145	CcSEcCtD
Oxymorphone—Urethral disorder—Methotrexate—multiple sclerosis	0.000424	0.00144	CcSEcCtD
Oxymorphone—Oedema—Dexamethasone—multiple sclerosis	0.000422	0.00144	CcSEcCtD
Oxymorphone—Oedema—Betamethasone—multiple sclerosis	0.000422	0.00144	CcSEcCtD
Oxymorphone—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000422	0.00144	CcSEcCtD
Oxymorphone—Insomnia—Triamcinolone—multiple sclerosis	0.000421	0.00143	CcSEcCtD
Oxymorphone—Insomnia—Methylprednisolone—multiple sclerosis	0.00042	0.00143	CcSEcCtD
Oxymorphone—Feeling abnormal—Prednisolone—multiple sclerosis	0.000417	0.00142	CcSEcCtD
Oxymorphone—Visual impairment—Methotrexate—multiple sclerosis	0.000417	0.00142	CcSEcCtD
Oxymorphone—Shock—Dexamethasone—multiple sclerosis	0.000415	0.00141	CcSEcCtD
Oxymorphone—Shock—Betamethasone—multiple sclerosis	0.000415	0.00141	CcSEcCtD
Oxymorphone—Dyspnoea—Triamcinolone—multiple sclerosis	0.000415	0.00141	CcSEcCtD
Oxymorphone—Nervous system disorder—Betamethasone—multiple sclerosis	0.000414	0.00141	CcSEcCtD
Oxymorphone—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000414	0.00141	CcSEcCtD
Oxymorphone—Agitation—Prednisone—multiple sclerosis	0.000414	0.00141	CcSEcCtD
Oxymorphone—Tachycardia—Betamethasone—multiple sclerosis	0.000412	0.0014	CcSEcCtD
Oxymorphone—Tachycardia—Dexamethasone—multiple sclerosis	0.000412	0.0014	CcSEcCtD
Oxymorphone—Dyspepsia—Triamcinolone—multiple sclerosis	0.000409	0.00139	CcSEcCtD
Oxymorphone—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000408	0.00139	CcSEcCtD
Oxymorphone—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000408	0.00139	CcSEcCtD
Oxymorphone—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000408	0.00139	CcSEcCtD
Oxymorphone—Vertigo—Prednisone—multiple sclerosis	0.000405	0.00138	CcSEcCtD
Oxymorphone—Eye disorder—Methotrexate—multiple sclerosis	0.000404	0.00138	CcSEcCtD
Oxymorphone—Syncope—Prednisone—multiple sclerosis	0.000404	0.00138	CcSEcCtD
Oxymorphone—Anorexia—Dexamethasone—multiple sclerosis	0.000402	0.00137	CcSEcCtD
Oxymorphone—Anorexia—Betamethasone—multiple sclerosis	0.000402	0.00137	CcSEcCtD
Oxymorphone—Urticaria—Prednisolone—multiple sclerosis	0.000402	0.00137	CcSEcCtD
Oxymorphone—Cardiac disorder—Methotrexate—multiple sclerosis	0.000401	0.00137	CcSEcCtD
Oxymorphone—Fatigue—Triamcinolone—multiple sclerosis	0.000401	0.00137	CcSEcCtD
Oxymorphone—Fatigue—Methylprednisolone—multiple sclerosis	0.0004	0.00136	CcSEcCtD
Oxymorphone—Pain—Triamcinolone—multiple sclerosis	0.000398	0.00135	CcSEcCtD
Oxymorphone—Loss of consciousness—Prednisone—multiple sclerosis	0.000396	0.00135	CcSEcCtD
Oxymorphone—Hypotension—Dexamethasone—multiple sclerosis	0.000394	0.00134	CcSEcCtD
Oxymorphone—Hypotension—Betamethasone—multiple sclerosis	0.000394	0.00134	CcSEcCtD
Oxymorphone—OPRD1—nervous system—multiple sclerosis	0.000394	0.0619	CbGeAlD
Oxymorphone—Angiopathy—Methotrexate—multiple sclerosis	0.000392	0.00134	CcSEcCtD
Oxymorphone—Vomiting—Mitoxantrone—multiple sclerosis	0.000392	0.00133	CcSEcCtD
Oxymorphone—Immune system disorder—Methotrexate—multiple sclerosis	0.00039	0.00133	CcSEcCtD
Oxymorphone—Convulsion—Prednisone—multiple sclerosis	0.00039	0.00133	CcSEcCtD
Oxymorphone—Mediastinal disorder—Methotrexate—multiple sclerosis	0.00039	0.00133	CcSEcCtD
Oxymorphone—Hypertension—Prednisone—multiple sclerosis	0.000389	0.00132	CcSEcCtD
Oxymorphone—Dermatitis—Mitoxantrone—multiple sclerosis	0.000388	0.00132	CcSEcCtD
Oxymorphone—Headache—Mitoxantrone—multiple sclerosis	0.000386	0.00132	CcSEcCtD
Oxymorphone—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000383	0.00131	CcSEcCtD
Oxymorphone—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000382	0.0013	CcSEcCtD
Oxymorphone—Anxiety—Prednisone—multiple sclerosis	0.000382	0.0013	CcSEcCtD
Oxymorphone—Insomnia—Betamethasone—multiple sclerosis	0.000382	0.0013	CcSEcCtD
Oxymorphone—Insomnia—Dexamethasone—multiple sclerosis	0.000382	0.0013	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000381	0.0013	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000379	0.00129	CcSEcCtD
Oxymorphone—OPRD1—central nervous system—multiple sclerosis	0.000379	0.0596	CbGeAlD
Oxymorphone—Mental disorder—Methotrexate—multiple sclerosis	0.000379	0.00129	CcSEcCtD
Oxymorphone—OPRK1—nervous system—multiple sclerosis	0.000378	0.0594	CbGeAlD
Oxymorphone—Malnutrition—Methotrexate—multiple sclerosis	0.000376	0.00128	CcSEcCtD
Oxymorphone—Hypersensitivity—Prednisolone—multiple sclerosis	0.000373	0.00127	CcSEcCtD
Oxymorphone—Dyspepsia—Betamethasone—multiple sclerosis	0.000371	0.00126	CcSEcCtD
Oxymorphone—Dyspepsia—Dexamethasone—multiple sclerosis	0.000371	0.00126	CcSEcCtD
Oxymorphone—Urticaria—Triamcinolone—multiple sclerosis	0.000369	0.00126	CcSEcCtD
Oxymorphone—Urticaria—Methylprednisolone—multiple sclerosis	0.000369	0.00126	CcSEcCtD
Oxymorphone—Body temperature increased—Triamcinolone—multiple sclerosis	0.000368	0.00125	CcSEcCtD
Oxymorphone—Oedema—Prednisone—multiple sclerosis	0.000368	0.00125	CcSEcCtD
Oxymorphone—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000367	0.00125	CcSEcCtD
Oxymorphone—Decreased appetite—Betamethasone—multiple sclerosis	0.000367	0.00125	CcSEcCtD
Oxymorphone—Decreased appetite—Dexamethasone—multiple sclerosis	0.000367	0.00125	CcSEcCtD
Oxymorphone—Nausea—Mitoxantrone—multiple sclerosis	0.000366	0.00125	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000364	0.00124	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000364	0.00124	CcSEcCtD
Oxymorphone—Fatigue—Betamethasone—multiple sclerosis	0.000364	0.00124	CcSEcCtD
Oxymorphone—Fatigue—Dexamethasone—multiple sclerosis	0.000364	0.00124	CcSEcCtD
Oxymorphone—OPRK1—central nervous system—multiple sclerosis	0.000364	0.0572	CbGeAlD
Oxymorphone—Shock—Prednisone—multiple sclerosis	0.000362	0.00123	CcSEcCtD
Oxymorphone—Pain—Betamethasone—multiple sclerosis	0.000361	0.00123	CcSEcCtD
Oxymorphone—Pain—Dexamethasone—multiple sclerosis	0.000361	0.00123	CcSEcCtD
Oxymorphone—Nervous system disorder—Prednisone—multiple sclerosis	0.00036	0.00123	CcSEcCtD
Oxymorphone—Tachycardia—Prednisone—multiple sclerosis	0.000359	0.00122	CcSEcCtD
Oxymorphone—Skin disorder—Prednisone—multiple sclerosis	0.000357	0.00122	CcSEcCtD
Oxymorphone—OPRK1—cerebellum—multiple sclerosis	0.000355	0.0559	CbGeAlD
Oxymorphone—Hyperhidrosis—Prednisone—multiple sclerosis	0.000355	0.00121	CcSEcCtD
Oxymorphone—Vision blurred—Methotrexate—multiple sclerosis	0.000355	0.00121	CcSEcCtD
Oxymorphone—Anorexia—Prednisone—multiple sclerosis	0.00035	0.00119	CcSEcCtD
Oxymorphone—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000348	0.00118	CcSEcCtD
Oxymorphone—Feeling abnormal—Betamethasone—multiple sclerosis	0.000348	0.00118	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000345	0.00118	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000345	0.00118	CcSEcCtD
Oxymorphone—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000343	0.00117	CcSEcCtD
Oxymorphone—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000342	0.00116	CcSEcCtD
Oxymorphone—Vertigo—Methotrexate—multiple sclerosis	0.000338	0.00115	CcSEcCtD
Oxymorphone—Urticaria—Dexamethasone—multiple sclerosis	0.000335	0.00114	CcSEcCtD
Oxymorphone—Urticaria—Betamethasone—multiple sclerosis	0.000335	0.00114	CcSEcCtD
Oxymorphone—Dizziness—Prednisolone—multiple sclerosis	0.000334	0.00114	CcSEcCtD
Oxymorphone—Asthenia—Triamcinolone—multiple sclerosis	0.000334	0.00114	CcSEcCtD
Oxymorphone—Abdominal pain—Dexamethasone—multiple sclerosis	0.000334	0.00114	CcSEcCtD
Oxymorphone—Abdominal pain—Betamethasone—multiple sclerosis	0.000334	0.00114	CcSEcCtD
Oxymorphone—Body temperature increased—Betamethasone—multiple sclerosis	0.000334	0.00114	CcSEcCtD
Oxymorphone—Body temperature increased—Dexamethasone—multiple sclerosis	0.000334	0.00114	CcSEcCtD
Oxymorphone—Asthenia—Methylprednisolone—multiple sclerosis	0.000333	0.00113	CcSEcCtD
Oxymorphone—Insomnia—Prednisone—multiple sclerosis	0.000332	0.00113	CcSEcCtD
Oxymorphone—Pruritus—Triamcinolone—multiple sclerosis	0.000329	0.00112	CcSEcCtD
Oxymorphone—Pruritus—Methylprednisolone—multiple sclerosis	0.000328	0.00112	CcSEcCtD
Oxymorphone—OPRM1—midbrain—multiple sclerosis	0.000327	0.0514	CbGeAlD
Oxymorphone—Convulsion—Methotrexate—multiple sclerosis	0.000326	0.00111	CcSEcCtD
Oxymorphone—Dyspepsia—Prednisone—multiple sclerosis	0.000324	0.0011	CcSEcCtD
Oxymorphone—Chest pain—Methotrexate—multiple sclerosis	0.00032	0.00109	CcSEcCtD
Oxymorphone—Decreased appetite—Prednisone—multiple sclerosis	0.000319	0.00109	CcSEcCtD
Oxymorphone—OPRM1—spinal cord—multiple sclerosis	0.000319	0.0501	CbGeAlD
Oxymorphone—Dermatitis—Prednisolone—multiple sclerosis	0.000319	0.00108	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000318	0.00108	CcSEcCtD
Oxymorphone—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000318	0.00108	CcSEcCtD
Oxymorphone—Fatigue—Prednisone—multiple sclerosis	0.000317	0.00108	CcSEcCtD
Oxymorphone—Headache—Prednisolone—multiple sclerosis	0.000317	0.00108	CcSEcCtD
Oxymorphone—Constipation—Prednisone—multiple sclerosis	0.000314	0.00107	CcSEcCtD
Oxymorphone—Confusional state—Methotrexate—multiple sclerosis	0.00031	0.00105	CcSEcCtD
Oxymorphone—Dizziness—Triamcinolone—multiple sclerosis	0.000308	0.00105	CcSEcCtD
Oxymorphone—Dizziness—Methylprednisolone—multiple sclerosis	0.000307	0.00104	CcSEcCtD
Oxymorphone—Feeling abnormal—Prednisone—multiple sclerosis	0.000303	0.00103	CcSEcCtD
Oxymorphone—Asthenia—Betamethasone—multiple sclerosis	0.000303	0.00103	CcSEcCtD
Oxymorphone—Asthenia—Dexamethasone—multiple sclerosis	0.000303	0.00103	CcSEcCtD
Oxymorphone—Nervous system disorder—Methotrexate—multiple sclerosis	0.000301	0.00103	CcSEcCtD
Oxymorphone—OPRD1—brain—multiple sclerosis	0.000301	0.0474	CbGeAlD
Oxymorphone—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000301	0.00102	CcSEcCtD
Oxymorphone—Nausea—Prednisolone—multiple sclerosis	0.0003	0.00102	CcSEcCtD
Oxymorphone—Pruritus—Dexamethasone—multiple sclerosis	0.000299	0.00102	CcSEcCtD
Oxymorphone—Pruritus—Betamethasone—multiple sclerosis	0.000299	0.00102	CcSEcCtD
Oxymorphone—Skin disorder—Methotrexate—multiple sclerosis	0.000298	0.00102	CcSEcCtD
Oxymorphone—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000297	0.00101	CcSEcCtD
Oxymorphone—Vomiting—Triamcinolone—multiple sclerosis	0.000296	0.00101	CcSEcCtD
Oxymorphone—Vomiting—Methylprednisolone—multiple sclerosis	0.000295	0.001	CcSEcCtD
Oxymorphone—Dermatitis—Triamcinolone—multiple sclerosis	0.000293	0.000998	CcSEcCtD
Oxymorphone—Anorexia—Methotrexate—multiple sclerosis	0.000293	0.000997	CcSEcCtD
Oxymorphone—Dermatitis—Methylprednisolone—multiple sclerosis	0.000292	0.000995	CcSEcCtD
Oxymorphone—Urticaria—Prednisone—multiple sclerosis	0.000292	0.000994	CcSEcCtD
Oxymorphone—Headache—Triamcinolone—multiple sclerosis	0.000291	0.000992	CcSEcCtD
Oxymorphone—Headache—Methylprednisolone—multiple sclerosis	0.000291	0.00099	CcSEcCtD
Oxymorphone—Abdominal pain—Prednisone—multiple sclerosis	0.000291	0.000989	CcSEcCtD
Oxymorphone—Body temperature increased—Prednisone—multiple sclerosis	0.000291	0.000989	CcSEcCtD
Oxymorphone—Diarrhoea—Dexamethasone—multiple sclerosis	0.000289	0.000983	CcSEcCtD
Oxymorphone—Diarrhoea—Betamethasone—multiple sclerosis	0.000289	0.000983	CcSEcCtD
Oxymorphone—OPRK1—brain—multiple sclerosis	0.000289	0.0454	CbGeAlD
Oxymorphone—Hypotension—Methotrexate—multiple sclerosis	0.000287	0.000977	CcSEcCtD
Oxymorphone—Dizziness—Betamethasone—multiple sclerosis	0.000279	0.00095	CcSEcCtD
Oxymorphone—Dizziness—Dexamethasone—multiple sclerosis	0.000279	0.00095	CcSEcCtD
Oxymorphone—Insomnia—Methotrexate—multiple sclerosis	0.000278	0.000946	CcSEcCtD
Oxymorphone—Nausea—Triamcinolone—multiple sclerosis	0.000276	0.000941	CcSEcCtD
Oxymorphone—Nausea—Methylprednisolone—multiple sclerosis	0.000276	0.000939	CcSEcCtD
Oxymorphone—Dyspnoea—Methotrexate—multiple sclerosis	0.000274	0.000932	CcSEcCtD
Oxymorphone—Somnolence—Methotrexate—multiple sclerosis	0.000273	0.00093	CcSEcCtD
Oxymorphone—Hypersensitivity—Prednisone—multiple sclerosis	0.000271	0.000922	CcSEcCtD
Oxymorphone—Dyspepsia—Methotrexate—multiple sclerosis	0.00027	0.000921	CcSEcCtD
Oxymorphone—OPRM1—nervous system—multiple sclerosis	0.000269	0.0423	CbGeAlD
Oxymorphone—Vomiting—Dexamethasone—multiple sclerosis	0.000268	0.000914	CcSEcCtD
Oxymorphone—Vomiting—Betamethasone—multiple sclerosis	0.000268	0.000914	CcSEcCtD
Oxymorphone—Decreased appetite—Methotrexate—multiple sclerosis	0.000267	0.000909	CcSEcCtD
Oxymorphone—Dermatitis—Dexamethasone—multiple sclerosis	0.000266	0.000905	CcSEcCtD
Oxymorphone—Dermatitis—Betamethasone—multiple sclerosis	0.000266	0.000905	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000265	0.000903	CcSEcCtD
Oxymorphone—Fatigue—Methotrexate—multiple sclerosis	0.000265	0.000902	CcSEcCtD
Oxymorphone—Headache—Dexamethasone—multiple sclerosis	0.000264	0.0009	CcSEcCtD
Oxymorphone—Headache—Betamethasone—multiple sclerosis	0.000264	0.0009	CcSEcCtD
Oxymorphone—Asthenia—Prednisone—multiple sclerosis	0.000264	0.000898	CcSEcCtD
Oxymorphone—Pain—Methotrexate—multiple sclerosis	0.000263	0.000894	CcSEcCtD
Oxymorphone—Pruritus—Prednisone—multiple sclerosis	0.00026	0.000885	CcSEcCtD
Oxymorphone—OPRM1—central nervous system—multiple sclerosis	0.000259	0.0407	CbGeAlD
Oxymorphone—Feeling abnormal—Methotrexate—multiple sclerosis	0.000253	0.000862	CcSEcCtD
Oxymorphone—Diarrhoea—Prednisone—multiple sclerosis	0.000251	0.000856	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000251	0.000855	CcSEcCtD
Oxymorphone—Nausea—Betamethasone—multiple sclerosis	0.000251	0.000854	CcSEcCtD
Oxymorphone—Nausea—Dexamethasone—multiple sclerosis	0.000251	0.000854	CcSEcCtD
Oxymorphone—Urticaria—Methotrexate—multiple sclerosis	0.000244	0.000831	CcSEcCtD
Oxymorphone—Dizziness—Prednisone—multiple sclerosis	0.000243	0.000828	CcSEcCtD
Oxymorphone—Abdominal pain—Methotrexate—multiple sclerosis	0.000243	0.000827	CcSEcCtD
Oxymorphone—Body temperature increased—Methotrexate—multiple sclerosis	0.000243	0.000827	CcSEcCtD
Oxymorphone—Vomiting—Prednisone—multiple sclerosis	0.000234	0.000796	CcSEcCtD
Oxymorphone—Dermatitis—Prednisone—multiple sclerosis	0.000232	0.000788	CcSEcCtD
Oxymorphone—Headache—Prednisone—multiple sclerosis	0.00023	0.000784	CcSEcCtD
Oxymorphone—Hypersensitivity—Methotrexate—multiple sclerosis	0.000226	0.000771	CcSEcCtD
Oxymorphone—Asthenia—Methotrexate—multiple sclerosis	0.00022	0.00075	CcSEcCtD
Oxymorphone—Nausea—Prednisone—multiple sclerosis	0.000218	0.000743	CcSEcCtD
Oxymorphone—Pruritus—Methotrexate—multiple sclerosis	0.000217	0.00074	CcSEcCtD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000211	0.00172	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—RGS1—multiple sclerosis	0.00021	0.00172	CbGpPWpGaD
Oxymorphone—Diarrhoea—Methotrexate—multiple sclerosis	0.00021	0.000716	CcSEcCtD
Oxymorphone—OPRM1—Signaling by GPCR—S1PR1—multiple sclerosis	0.000209	0.00171	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CCR1—multiple sclerosis	0.000208	0.0017	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000208	0.0017	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—PTGER4—multiple sclerosis	0.000206	0.00168	CbGpPWpGaD
Oxymorphone—OPRM1—G alpha (i) signalling events—CCR5—multiple sclerosis	0.000206	0.00168	CbGpPWpGaD
Oxymorphone—CYP2D6—brainstem—multiple sclerosis	0.000206	0.0323	CbGeAlD
Oxymorphone—OPRM1—brain—multiple sclerosis	0.000205	0.0323	CbGeAlD
Oxymorphone—Dizziness—Methotrexate—multiple sclerosis	0.000203	0.000692	CcSEcCtD
Oxymorphone—OPRK1—GPCR downstream signaling—CCR1—multiple sclerosis	0.000201	0.00164	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000201	0.00164	CbGpPWpGaD
Oxymorphone—OPRM1—TCR Signaling Pathway—TGFB1—multiple sclerosis	0.0002	0.00163	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—GPR65—multiple sclerosis	0.000199	0.00163	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—CXCR3—multiple sclerosis	0.000199	0.00162	CbGpPWpGaD
Oxymorphone—OPRM1—TCR Signaling Pathway—MAPK1—multiple sclerosis	0.000196	0.0016	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—RGS1—multiple sclerosis	0.000196	0.0016	CbGpPWpGaD
Oxymorphone—Vomiting—Methotrexate—multiple sclerosis	0.000195	0.000665	CcSEcCtD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000194	0.00158	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—CCR2—multiple sclerosis	0.000194	0.00158	CbGpPWpGaD
Oxymorphone—Dermatitis—Methotrexate—multiple sclerosis	0.000193	0.000659	CcSEcCtD
Oxymorphone—OPRK1—Signaling Pathways—LINGO1—multiple sclerosis	0.000193	0.00157	CbGpPWpGaD
Oxymorphone—Headache—Methotrexate—multiple sclerosis	0.000192	0.000655	CcSEcCtD
Oxymorphone—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000191	0.00156	CbGpPWpGaD
Oxymorphone—OPRM1—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.000191	0.00156	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TAGAP—multiple sclerosis	0.000191	0.00156	CbGpPWpGaD
Oxymorphone—OPRK1—G alpha (i) signalling events—POMC—multiple sclerosis	0.000191	0.00155	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—CXCL10—multiple sclerosis	0.00019	0.00155	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—CCL5—multiple sclerosis	0.000187	0.00152	CbGpPWpGaD
Oxymorphone—OPRM1—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.000187	0.00152	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—GPR65—multiple sclerosis	0.000186	0.00151	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000182	0.00149	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CCR1—multiple sclerosis	0.000182	0.00149	CbGpPWpGaD
Oxymorphone—Nausea—Methotrexate—multiple sclerosis	0.000182	0.000621	CcSEcCtD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000182	0.00148	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—CNR1—multiple sclerosis	0.000179	0.00146	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—RGS1—multiple sclerosis	0.000178	0.00145	CbGpPWpGaD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000173	0.00141	CbGpPWpGaD
Oxymorphone—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000172	0.0014	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.00017	0.00139	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CCR1—multiple sclerosis	0.00017	0.00139	CbGpPWpGaD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000169	0.00138	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—GPR65—multiple sclerosis	0.000169	0.00138	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—CCR5—multiple sclerosis	0.000168	0.00137	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TAGAP—multiple sclerosis	0.000167	0.00136	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—S1PR1—multiple sclerosis	0.000167	0.00136	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—CCL5—multiple sclerosis	0.000164	0.00134	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000164	0.00134	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—LINGO1—multiple sclerosis	0.000163	0.00133	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—GPC5—multiple sclerosis	0.000162	0.00132	CbGpPWpGaD
Oxymorphone—OPRM1—G alpha (i) signalling events—POMC—multiple sclerosis	0.000161	0.00131	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—CXCL10—multiple sclerosis	0.000161	0.00131	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000157	0.00128	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CCR1—multiple sclerosis	0.000154	0.00126	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000154	0.00126	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000152	0.00124	CbGpPWpGaD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000152	0.00124	CbGpPWpGaD
Oxymorphone—OPRM1—TCR Signaling Pathway—IL6—multiple sclerosis	0.000151	0.00123	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CCL3—multiple sclerosis	0.000148	0.00121	CbGpPWpGaD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000148	0.00121	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000148	0.0012	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—CCR5—multiple sclerosis	0.000148	0.0012	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—S1PR1—multiple sclerosis	0.000146	0.00119	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000143	0.00116	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—GPC5—multiple sclerosis	0.000142	0.00116	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—RGS1—multiple sclerosis	0.000142	0.00116	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TAGAP—multiple sclerosis	0.000141	0.00115	CbGpPWpGaD
Oxymorphone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000139	0.00113	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—CCL5—multiple sclerosis	0.000139	0.00113	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000138	0.00112	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000138	0.00112	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000136	0.00111	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—GPR65—multiple sclerosis	0.000134	0.0011	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CCR2—multiple sclerosis	0.000134	0.00109	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000133	0.00109	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—POMC—multiple sclerosis	0.000132	0.00107	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CCL3—multiple sclerosis	0.00013	0.00106	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000129	0.00106	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—CCL2—multiple sclerosis	0.000129	0.00105	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000128	0.00104	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000125	0.00102	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000125	0.00102	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—CCR5—multiple sclerosis	0.000125	0.00102	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—RGS1—multiple sclerosis	0.000124	0.00101	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CNR1—multiple sclerosis	0.000124	0.00101	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—S1PR1—multiple sclerosis	0.000124	0.00101	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CCR1—multiple sclerosis	0.000123	0.001	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CXCL13—multiple sclerosis	0.000123	0.001	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000123	0.001	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000121	0.000986	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—GPC5—multiple sclerosis	0.00012	0.000981	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000119	0.000975	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—GPR65—multiple sclerosis	0.000118	0.000961	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CCR2—multiple sclerosis	0.000118	0.000959	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000116	0.00095	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—POMC—multiple sclerosis	0.000115	0.000941	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—CCL2—multiple sclerosis	0.000113	0.000921	CbGpPWpGaD
Oxymorphone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000112	0.000918	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000112	0.000918	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000111	0.000909	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CCL3—multiple sclerosis	0.00011	0.000896	CbGpPWpGaD
Oxymorphone—CYP3A4—nervous system—multiple sclerosis	0.000109	0.0172	CbGeAlD
Oxymorphone—OPRM1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000109	0.000893	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CNR1—multiple sclerosis	0.000109	0.000885	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCR1—multiple sclerosis	0.000108	0.000879	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CXCL13—multiple sclerosis	0.000108	0.000879	CbGpPWpGaD
Oxymorphone—CYP2D6—nervous system—multiple sclerosis	0.000108	0.0169	CbGeAlD
Oxymorphone—OPRK1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000108	0.000878	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000106	0.000863	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000106	0.000862	CbGpPWpGaD
Oxymorphone—CYP3A4—central nervous system—multiple sclerosis	0.000105	0.0166	CbGeAlD
Oxymorphone—OPRM1—Signaling Pathways—RGS1—multiple sclerosis	0.000105	0.000857	CbGpPWpGaD
Oxymorphone—CYP2D6—central nervous system—multiple sclerosis	0.000104	0.0163	CbGeAlD
Oxymorphone—OPRM1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000102	0.000833	CbGpPWpGaD
Oxymorphone—CYP2D6—cerebellum—multiple sclerosis	0.000101	0.0159	CbGeAlD
Oxymorphone—OPRM1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000101	0.000824	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—GPR65—multiple sclerosis	9.96e-05	0.000813	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CCR2—multiple sclerosis	9.94e-05	0.000811	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—SRM—multiple sclerosis	9.86e-05	0.000805	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CXCL10—multiple sclerosis	9.77e-05	0.000797	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—POMC—multiple sclerosis	9.75e-05	0.000796	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CCL5—multiple sclerosis	9.59e-05	0.000782	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—CCL2—multiple sclerosis	9.54e-05	0.000778	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—CCR5—multiple sclerosis	9.52e-05	0.000776	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—IL2RA—multiple sclerosis	9.38e-05	0.000765	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—CCL5—multiple sclerosis	9.26e-05	0.000756	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CNR1—multiple sclerosis	9.17e-05	0.000748	CbGpPWpGaD
Oxymorphone—CYP2D6—Biological oxidations—POMC—multiple sclerosis	9.14e-05	0.000746	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CXCL13—multiple sclerosis	9.11e-05	0.000743	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCR1—multiple sclerosis	9.11e-05	0.000743	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	9.09e-05	0.000742	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CCL3—multiple sclerosis	8.76e-05	0.000715	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CCR5—multiple sclerosis	8.64e-05	0.000705	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—IL2RA—multiple sclerosis	8.52e-05	0.000695	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PTGER4—multiple sclerosis	8.43e-05	0.000688	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CCL5—multiple sclerosis	8.41e-05	0.000686	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—CCR5—multiple sclerosis	8.34e-05	0.000681	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PGR—multiple sclerosis	8.3e-05	0.000677	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CXCL10—multiple sclerosis	8.26e-05	0.000674	CbGpPWpGaD
Oxymorphone—CYP2D6—brain—multiple sclerosis	8.23e-05	0.0129	CbGeAlD
Oxymorphone—OPRK1—GPCR downstream signaling—IL2RA—multiple sclerosis	8.22e-05	0.000671	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CXCR3—multiple sclerosis	8.14e-05	0.000664	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CD28—multiple sclerosis	8.07e-05	0.000658	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CCR2—multiple sclerosis	7.92e-05	0.000646	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CCL5—multiple sclerosis	7.83e-05	0.000639	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCL3—multiple sclerosis	7.68e-05	0.000627	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CCR5—multiple sclerosis	7.58e-05	0.000618	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—IL2RA—multiple sclerosis	7.47e-05	0.000609	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—POMC—multiple sclerosis	7.44e-05	0.000607	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PTGER4—multiple sclerosis	7.39e-05	0.000603	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CNR1—multiple sclerosis	7.31e-05	0.000596	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PGR—multiple sclerosis	7.28e-05	0.000594	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CXCR3—multiple sclerosis	7.14e-05	0.000582	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CCL5—multiple sclerosis	7.11e-05	0.00058	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CD28—multiple sclerosis	7.07e-05	0.000577	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CCR5—multiple sclerosis	7.05e-05	0.000575	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	6.95e-05	0.000567	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	6.95e-05	0.000567	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	6.95e-05	0.000567	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCR2—multiple sclerosis	6.95e-05	0.000567	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—POMC—multiple sclerosis	6.75e-05	0.000551	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CCL2—multiple sclerosis	6.61e-05	0.000539	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CXCL10—multiple sclerosis	6.58e-05	0.000537	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—POMC—multiple sclerosis	6.52e-05	0.000532	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCL3—multiple sclerosis	6.49e-05	0.00053	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—SRM—multiple sclerosis	6.45e-05	0.000526	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CNR1—multiple sclerosis	6.41e-05	0.000523	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CCR5—multiple sclerosis	6.4e-05	0.000522	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GPC5—multiple sclerosis	6.36e-05	0.000518	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—IL2RA—multiple sclerosis	6.31e-05	0.000515	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PTGER4—multiple sclerosis	6.25e-05	0.00051	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PGR—multiple sclerosis	6.15e-05	0.000502	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CXCR3—multiple sclerosis	6.03e-05	0.000492	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—TYK2—multiple sclerosis	6e-05	0.000489	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CD28—multiple sclerosis	5.98e-05	0.000488	CbGpPWpGaD
Oxymorphone—CYP3A4—Biological oxidations—POMC—multiple sclerosis	5.98e-05	0.000487	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—POMC—multiple sclerosis	5.92e-05	0.000483	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCR2—multiple sclerosis	5.87e-05	0.000479	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CCL2—multiple sclerosis	5.79e-05	0.000473	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CXCL10—multiple sclerosis	5.77e-05	0.000471	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CD86—multiple sclerosis	5.76e-05	0.00047	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CCL5—multiple sclerosis	5.67e-05	0.000462	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—POMC—multiple sclerosis	5.51e-05	0.00045	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—IL2—multiple sclerosis	5.5e-05	0.000448	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CNR1—multiple sclerosis	5.42e-05	0.000442	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—RRM1—multiple sclerosis	5.27e-05	0.00043	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—TYK2—multiple sclerosis	5.26e-05	0.000429	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—SPP1—multiple sclerosis	5.25e-05	0.000428	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CCR5—multiple sclerosis	5.1e-05	0.000416	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CD86—multiple sclerosis	5.05e-05	0.000412	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IL2RA—multiple sclerosis	5.03e-05	0.00041	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—POMC—multiple sclerosis	5e-05	0.000408	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—IL2—multiple sclerosis	4.99e-05	0.000407	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCL5—multiple sclerosis	4.97e-05	0.000405	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CCL2—multiple sclerosis	4.9e-05	0.000399	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CXCL10—multiple sclerosis	4.88e-05	0.000398	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—IL2—multiple sclerosis	4.82e-05	0.000393	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—APOE—multiple sclerosis	4.64e-05	0.000379	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—SPP1—multiple sclerosis	4.6e-05	0.000375	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	4.54e-05	0.000371	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	4.54e-05	0.000371	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCR5—multiple sclerosis	4.48e-05	0.000365	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—TYK2—multiple sclerosis	4.45e-05	0.000363	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IL2RA—multiple sclerosis	4.41e-05	0.00036	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—IL2—multiple sclerosis	4.38e-05	0.000357	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CD86—multiple sclerosis	4.27e-05	0.000348	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCL5—multiple sclerosis	4.2e-05	0.000343	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CD80—multiple sclerosis	4.2e-05	0.000343	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GPC5—multiple sclerosis	4.15e-05	0.000339	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—IL2—multiple sclerosis	4.07e-05	0.000332	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—APOE—multiple sclerosis	4.07e-05	0.000332	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—POMC—multiple sclerosis	3.99e-05	0.000325	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CCL2—multiple sclerosis	3.9e-05	0.000318	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—SPP1—multiple sclerosis	3.89e-05	0.000317	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—MAPK1—multiple sclerosis	3.82e-05	0.000312	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCR5—multiple sclerosis	3.78e-05	0.000309	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IL2RA—multiple sclerosis	3.73e-05	0.000304	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—IL2—multiple sclerosis	3.7e-05	0.000302	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CD80—multiple sclerosis	3.68e-05	0.0003	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TYK2—multiple sclerosis	3.54e-05	0.000289	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—POMC—multiple sclerosis	3.5e-05	0.000285	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—RRM1—multiple sclerosis	3.44e-05	0.000281	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—APOE—multiple sclerosis	3.44e-05	0.000281	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCL2—multiple sclerosis	3.42e-05	0.000279	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—MAPK1—multiple sclerosis	3.35e-05	0.000273	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CD80—multiple sclerosis	3.11e-05	0.000254	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TYK2—multiple sclerosis	3.11e-05	0.000254	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—BCHE—multiple sclerosis	3.02e-05	0.000247	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—POMC—multiple sclerosis	2.96e-05	0.000241	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IL2—multiple sclerosis	2.95e-05	0.000241	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—IL6—multiple sclerosis	2.93e-05	0.000239	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCL2—multiple sclerosis	2.89e-05	0.000236	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—MAPK1—multiple sclerosis	2.83e-05	0.000231	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MMP9—multiple sclerosis	2.79e-05	0.000228	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TYK2—multiple sclerosis	2.63e-05	0.000214	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IL2—multiple sclerosis	2.59e-05	0.000211	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—IL6—multiple sclerosis	2.57e-05	0.00021	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—STAT3—multiple sclerosis	2.48e-05	0.000202	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MMP9—multiple sclerosis	2.45e-05	0.0002	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MYC—multiple sclerosis	2.31e-05	0.000188	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TGFB1—multiple sclerosis	2.3e-05	0.000188	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MAPK1—multiple sclerosis	2.26e-05	0.000184	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IL2—multiple sclerosis	2.19e-05	0.000178	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—STAT3—multiple sclerosis	2.18e-05	0.000178	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—IL6—multiple sclerosis	2.17e-05	0.000177	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MMP9—multiple sclerosis	2.07e-05	0.000169	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MYC—multiple sclerosis	2.02e-05	0.000165	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TGFB1—multiple sclerosis	2.02e-05	0.000165	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MAPK1—multiple sclerosis	1.98e-05	0.000161	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.98e-05	0.000161	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—STAT3—multiple sclerosis	1.84e-05	0.00015	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—APOE—multiple sclerosis	1.82e-05	0.000148	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IL6—multiple sclerosis	1.73e-05	0.000141	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MYC—multiple sclerosis	1.71e-05	0.000139	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TGFB1—multiple sclerosis	1.7e-05	0.000139	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MAPK1—multiple sclerosis	1.67e-05	0.000136	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—POMC—multiple sclerosis	1.56e-05	0.000128	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IL6—multiple sclerosis	1.52e-05	0.000124	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ALB—multiple sclerosis	1.43e-05	0.000116	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IL6—multiple sclerosis	1.28e-05	0.000105	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—APOE—multiple sclerosis	1.19e-05	9.7e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—POMC—multiple sclerosis	1.02e-05	8.34e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ALB—multiple sclerosis	9.32e-06	7.6e-05	CbGpPWpGaD
